Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04132648
Other study ID # 201907819
Secondary ID
Status Withdrawn
Phase Phase 2
First received
Last updated
Start date November 15, 2020
Est. completion date November 1, 2021

Study information

Verified date February 2023
Source University of Iowa
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic kidney disease (CKD) is associated with a pro-oxidative and pro-inflammatory state, and this is thought to contribute to a decrease in vascular function leading to greater cardiovascular disease (CVD) risk. Curcumin supplementation has been shown to reduce oxidative stress and improve endothelial function at rest in healthy older humans, although the magnitude of this effect remains unknown during exercise in CKD. The primary aim of this proposal is to determine whether exercising blood flow and vasoconstrictor responsiveness are improved as a result of acute oral supplementation with curcumin in patients with CKD. We hypothesize that: 1) acute curcumin supplementation will increase steady state exercise blood flow, and 2) reduce vasoconstriction induced by an acute sympathetic stimulus (cold pressor test) CKD.


Description:

Active muscles require an optimal amount of local blood flow to meet the functional and metabolic demand of the exercising muscle. It is well known that maximal aerobic work capacity and exercise tolerance are reduced in CKD, contributing to functional impairment and loss of independence. A multitude of factors may be responsible for this outcome including reduced blood flow to active muscle beds brought on by greater levels of oxidative stress in CKD. Aging and some individuals with disease (coronary artery disease, hypertension, diabetes) exhibit elevated resting sympathetic nerve activity (SNA), leading to greater vasoconstriction and pressor responses during exercise. However, the magnitude of this effect remains unknown in CKD. Importantly, there are a lack of interventions aimed at improving blood flow and reduce sympathetic mediated vasoconstriction in patients with CKD. Recent evidence in aging humans suggest that curcumin supplementation improves vascular function by reducing oxidative stress. However, it remains unknown whether acute curcumin supplementation can be regarded as an effective therapeutic strategy aimed at modulating exercise vasodilation and sympathetic mediated vasoconstriction in CKD. Understanding the mechanisms that impair vascular function within exercising muscle is important when understanding implications for systemic blood pressure regulation, cardiovascular disease and functional work capacity in CKD. Therefore, identifying a low cost, non-pharmaceutical intervention and its potential impact on improving vascular function in CKD is a priority in preventative cardiovascular disease medicine. The present proposal aims to examine the effect of sympathetic vasoconstriction on the differential changes in exercising blood flow in response to acute oral supplementation with curcumin in patients with CKD.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date November 1, 2021
Est. primary completion date November 1, 2021
Accepts healthy volunteers No
Gender All
Age group 45 Years to 80 Years
Eligibility Inclusion Criteria for CKD subjects: Age 45-80 years old CKD stage III and IV (estimated glomerular filtration rate: 15-60 mL/min/1.73m2) BMI <40 kg/m2-1 Able to give informed consent Exclusion Criteria for CKD subjects will include answering yes to the following questions: - Active participation in another study? - Dialysis? - End stage renal disease or kidney failure? - Kidney transplant? - Sever liver disease or transplant? - Diabetes? - Angina (i.e., chest discomfort/pain/pressure upon exertion) - Severe congestive heart failure? - Pacemaker/defibrillator? - Heart arrhythmia (i.e. Atrial fibrillation/flutter)? - Pregnant, breastfeeding, or unwilling to use adequate birth control? - Active infection or antibiotic therapy? - Immunosuppressive therapy within the last 3 months? - History of stroke? - Have you had a heart attack in the last 3 months? - Have you taken curcumin in last 3 months? - Current use of Hormone Replacement Therapy (if female)? - Current smoker? - Anemic (Hemoglobin count <9)? Inclusion Criteria for healthy middle-age and older subjects: Age 45-80 years old BMI <40 kg/m2 1 Able to give informed consent Exclusion Criteria for health older subjects will include answering yes to the following questions: - Chronic kidney disease? - Hypertension? - Asthma? - Heart disease? - Clinical depression? - Autonomic disorders? - Sleep apnea? - Sever liver disease or transplant? - Diabetes? - Heart attack? - Angina (i.e., chest discomfort/pain/pressure upon exertion) - Severe systolic or congestive heart failure? - Heart angioplasty/stent or bypass surgery? - Heart valve surgery/replacement or valve disease? - Pacemaker/defibrillator? - Heart arrhythmia (i.e. Atrial fibrillation/flutter)? - Pregnant, breastfeeding, or unwilling to use adequate birth control? - Active infection or antibiotic therapy? - Immunosuppressive therapy within the last 3 months? - Have you taken curcumin in last 3 months? - Current use of Hormone Replacement Therapy (if female)? - Current smoker? - Anemic (Hemoglobin count <9)?

Study Design


Intervention

Drug:
Curcumin
Oral supplement one time at 2,000 mg
Other:
Placebo
Oral supplement one time at 2,000 mg

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Iowa

Outcome

Type Measure Description Time frame Safety issue
Primary %change forearm vascular condutance (FVC) Percentage reduction in FVC in response to acute sympathetic stimulus (cold pressor test; CPT) 2 hours
Secondary forearm blood flow (FBF) steady state FBF during forearm hand-grip exercise and CPT 2 hours
See also
  Status Clinical Trial Phase
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT05997303 - Continuous Norepinephrine Administration and Blood Pressure Stability During Anesthetic Induction N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT03918486 - Caretaker vs. Routine Blood Pressure Sphygmomanometer
Completed NCT03410342 - The Effects of Types of Fruits and Vegetables on Vascular Function N/A
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT04087070 - Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia
Completed NCT03294928 - Arterial Waveform Analysis Applying Different Positive End-Expiratory Pressure (PEEP) Levels in Healthy Volunteers N/A
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03997461 - Comparison of Arterial Tonometry Sensor With Standard Oscillometric Blood Pressure Monitoring Device N/A
Completed NCT03290716 - Diet, ExerCIse and carDiovascular hEalth (DECIDE) - Salt Reduction Strategies for the Elderly in Nursing Homes in China N/A
Recruiting NCT05196048 - Blood Pressure Sensor of Watch-type Device With ECG Technology
Recruiting NCT06460233 - Blood Pressure Changes After Bariatric Surgery
Terminated NCT03325933 - Resistance Training and Cardiometabolic Health N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Completed NCT02924454 - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol. Phase 4
Completed NCT02451059 - Reducing Socioeconomic Disparities in Health at Pediatric Visits N/A
Active, not recruiting NCT02670967 - Effects of Soluble Fiber on Blood Pressure: A Meta-analysis of Randomly-controlled Trials N/A
Completed NCT02239744 - Intervention Study on the Health Impact of Air Filters in Chinese Adults N/A
Completed NCT02271633 - Nitrate Supplementation; Source Phase 4